|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 27 July 2022, 9:12. The announcement is marked as price sensitive, and is 12 page(s) in length and 518.09kb in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.002% short sold according to ASIC data. It was ranked the 630th most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| IIQ Appendix 4C & Quarterly Activities Report - June 2022 | 27 July 2022, 9:12 |
| Positive SubB2M IHC Results for Melanoma | 26 July 2022, 10:19 |
| hTERT US Patent Granted | 22 July 2022, 9:00 |
| INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out | 21 July 2022, 8:46 |
You must be logged in to post a reply.
